Genta Appoints Dr. Per Lindell as Vice President of Business Development
Role focused on driving growth, identifying new market opportunities and expanding strategic partnerships
Genta Incorporated announced the appointment of Dr. Per I. Lindell, Sc.D., as Vice President of business development. At Genta, Dr. Lindell will have broad responsibility for expanding the Company's worldwide business development activities, including partnering negotiations for the Company's lead anticancer product, Genasense® (oblimersen sodium) Injection, as well as inlicensing and acquisition of new products and technology.
Dr. Lindell has nearly 20 years of experience in the pharmaceutical industry. He was most recently Vice President, Corporate Development, at Metaphore Pharmaceuticals. Until 2003, he was Vice President, Business Development, at Avalon Pharmaceuticals in Maryland. From 1998 to 2001, Dr. Lindell was Senior Director, Business Development, New Product Launches and Strategic Planning, at Knoll Pharmaceuticals, a division of BASF. He had previously served as a management consultant with the Boston Consulting Group and Arthur D. Little, and as a Research Engineer at Pharmacia AB in Uppsala, Sweden. Dr. Lindell received a Doctor of Science degree in Biochemical Engineering from the Massachusetts Institute of Technology in Cambridge and a Master of Science degree in Chemical Engineering from the Royal Institute of Technology in Stockholm.
Other news from the department people
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.
